文献速递流行病学与生物统计医学教育与科研方法

优化晚期结核病临床试验的招募:一项探索乌兹别克斯坦患者和医生体验的定性研究

Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan.
PubMed 文献 · Trials · 2021-12-04

该定性研究通过深度访谈和焦点小组讨论,探索乌兹别克斯坦患者和医务人员参与一项耐多药结核病II/III期随机对照临床试验的招募障碍与促进因素。研究发现卫生系统背景、信任以及动态决策过程影响患者参与试验,患者和医务人员共同开发的见解可能有助于改善试验招募。

要点

  • 卫生系统法规与员工信念可能削弱临床试验招募。
  • 信任在患者参与试验中起重要作用。
  • 决策过程是动态的,与诊断关系、信息吸收、既往知识和亲友影响相关。

核心结论

  • 该定性分析强调,与患者和医务人员共同开发的见解可能为改善试验招募提供信息,总体目标是提供更好治疗方案的证据。

研究设计与样本

  • 定性研究,采用最大变异目的性抽样,于2019年12月和2020年1月对患者、卫生部(MoH)和无国界医生(MSF)工作人员及试验卫生工作者进行26次深度访谈,随后与患者、护士和咨询员进行3次焦点小组讨论。

主要发现

  • 卫生系统背景可能与新方法竞争,尤其是当围绕治疗的立法卫生法规或政策根植于员工信念、认知和实践时,可能削弱临床试验招募。
  • 信任在患者如何参与试验中起重要作用。
  • 决策过程是动态的,与诊断关系、信息吸收、既往知识或经验以及同伴和近亲的影响相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Addressing the global burden of multidrug-resistant tuberculosis (MDR-TB) requires identification of shorter, less toxic treatment regimens. Médecins Sans Frontières (MSF) is currently conducting a phase II/III randomised controlled clinical trial, to find more effective, shorter and tolerable treatments for people with MDR-TB. Recruitment to the trial in Uzbekistan has been slower than expected; we aimed to study patient and health worker experiences of the trial, examining potential factors perceived to impede and facilitate trial recruitment, as well as general perceptions of clinical research in this context. METHODS: We conducted a qualitative study using maximum variation, purposive sampling of participants. We carried out in-depth interviews (IDIs) and focus group discussions (FGDs) guided by semi-structured topic guides. In December 2019 and January 2020, 26 interviews were conducted with patients, Ministry of Health (MoH) and MSF staff and trial health workers, to explore challenges and barriers to patient recruitment as well as perceptions of the trial and research in general. Preliminary findings from the interviews informed three subsequent focus group discussions held with patients, nurses and counsellors. Focus groups adopted a person-centred design, brainstorming potential solutions to problems and barriers. Interviews and FGDs were audio recorded, translated and transcribed verbatim. Thematic analysis, drawing on constant comparison, was used to analyse the data. RESULTS: Health system contexts may compete with new approaches especially when legislative health regulations or policy around treatment is ingrained in staff beliefs, perceptions and practice, which can undermine clinical trial recruitment. Trust plays a significant role in how patients engage with the trial. Decision-making processes are dynamic and associated with relationship to diagnosis, assimilation of information, previous knowledge or experience and influence of peers and close relations. CONCLUSIONS: This qualitative analysis highlights ways in which insights developed together with patients and healthcare workers might inform approaches towards improved recruitment into trials, with the overall objective of delivering evidence for better treatments.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wharton-Smith A, Horter S, Douch E, et al. Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan. Trials. 2021. PMID: 34863253. doi:10.1186/s13063-021-05850-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。